Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Simon Tchekmedyian

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Oncology (Williston Park, N.Y.)|October 17, 2002
Anemia in cancer patients: significance, epidemiology, and current therapyN Simon Tchekmedyian
Oncology (Williston Park, N.Y.)|November 19, 2002
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapyJohn A Glaspy, N Simon Tchekmedyian
Cancer Investigation|July 2, 2010
Disease progression increases the risk of skeletal-related events in patients with bone metastases from castration-resistant prostate cancer, lung cancer, or other solid tumorsN Simon Tchekmedyian, Yin-Miao Chen, Fred Saad
Clinical Drug Investigation|December 14, 2006
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfaKenneth R Meehan, N Simon Tchekmedyian, Robert E Smith, et al.
Cancer|July 2, 2003
The relationship between psychologic distress and cancer-related fatigueN Simon Tchekmedyian, Joel Kallich, Anne McDermott, et al.
Clinical Lung Cancer|November 24, 2004
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complicationsVera Hirsh, N Simon Tchekmedyian, Lee S Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancerEric J Small, N Simon Tchekmedyian, Brian I Rini, et al.
Supportive Cancer Therapy|July 17, 2008
Hemoglobin increase is associated with improved health-related quality of life in patients with cancer not receiving chemotherapyJr Robert E Smith, John A Glaspy, N Simon Tchekmedyian, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Psychological outcomes associated with anemia-related fatigue in cancer patientsJoel D Kallich, N Simon Tchekmedyian, Anne M Damiano, et al.
BMC Cancer|October 27, 2012
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumoursMark J McKeage, Michael B Jameson, Ramesh K Ramanathan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|October 17, 2002
Anemia in cancer patients: significance, epidemiology, and current therapyN Simon Tchekmedyian
Oncology (Williston Park, N.Y.)|November 19, 2002
Darbepoetin alfa administered every 2 weeks alleviates anemia in cancer patients receiving chemotherapyJohn A Glaspy, N Simon Tchekmedyian
Cancer Investigation|July 2, 2010
Disease progression increases the risk of skeletal-related events in patients with bone metastases from castration-resistant prostate cancer, lung cancer, or other solid tumorsN Simon Tchekmedyian, Yin-Miao Chen, Fred Saad
Clinical Drug Investigation|December 14, 2006
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfaKenneth R Meehan, N Simon Tchekmedyian, Robert E Smith, et al.
Cancer|July 2, 2003
The relationship between psychologic distress and cancer-related fatigueN Simon Tchekmedyian, Joel Kallich, Anne McDermott, et al.
Clinical Lung Cancer|November 24, 2004
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complicationsVera Hirsh, N Simon Tchekmedyian, Lee S Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancerEric J Small, N Simon Tchekmedyian, Brian I Rini, et al.
Supportive Cancer Therapy|July 17, 2008
Hemoglobin increase is associated with improved health-related quality of life in patients with cancer not receiving chemotherapyJr Robert E Smith, John A Glaspy, N Simon Tchekmedyian, et al.
Oncology (Williston Park, N.Y.)|October 17, 2002
Psychological outcomes associated with anemia-related fatigue in cancer patientsJoel D Kallich, N Simon Tchekmedyian, Anne M Damiano, et al.
BMC Cancer|October 27, 2012
PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumoursMark J McKeage, Michael B Jameson, Ramesh K Ramanathan, et al.
Pageof 2